Come up with a name for your new list and we'll add to it:
Tiltan Pharma raised a round of funding on September 09, 2010. Investors include
Israel Innovation Authority.
Tiltan Pharma is a biotechnology company dedicated to the development and commercialization of its proprietary anti-angiogenic platform for the treatment of cancer and other indications. The Company i…